9 INCLUSION OF PHASE II PORTION OF THE STUDY As in the phase I portion but only patients with AML or high-risk MDS blasts or 10 including untreated patients older than 60 years of age with AML or MDS who refuse or are not eligible for frontline chemotherapy will be eligible in this portion of the study 